Results 201 to 210 of about 167,720 (353)

Interleukin-1 Receptor Antagonist Protects against Lipopolysaccharide Induced Diaphragm Weakness in Preterm Lambs

, 2015
Kanakeswary Karisnan, Anthony J. Bakker, Yong Song, Peter B. Noble, J. Jane Pillow, Gavin J. Pinniger   +5 more
openalex   +2 more sources

Tubule‐Derived IFN‐α Promotes GSDMD‐Mediated Macrophage Pyroptosis to Drive Renal Inflammation and Fibrosis Through JAK2/STAT2 Activation

Advanced Science, EarlyView.
Mao and colleagues uncover a STAT2/IRF9‐dependent signaling axis through which tubular epithelial cell (TEC)‐derived IFN‐α induces gasdermin D (GSDMD)‐mediated pyroptosis in macrophages. This TEC‐macrophage feedback loop amplifies renal inflammation and fibrosis, providing mechanistic insight into the progression of chronic kidney disease and revealing
Yiping Xu, Yating Wang, Siming Jiang, Yi Li, Guanglan Li, Yuchu Liu, Siyuan Li, Yiming Zhou, Qinghua Liu, Yi Zhou, Wei Chen, Hongyu Li, Haiping Mao   +12 more
wiley   +1 more source

Deficiency of interleukin-1 receptor antagonist aggravates Citrobacter rodentium infection in mice. [PDF]

Immunohorizons
Yeoh BS, Saha P, Kushwaha V, Gohara AF, Vijay-Kumar M.   +4 more
europepmc   +1 more source

Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy. [PDF]

Biomed Res Int, 2022
Liao X, Xiao Y, Elbelt U, Weylandt KH, Li K, Deng J, Zeng N, Xue C.   +7 more
europepmc   +1 more source

Interleukin‐1 Receptor Antagonist Gene Polymorphism and Cancer [PDF]

Clinical Infectious Diseases, 2002
Jalid, Sehouli, Alexander, Mustea
openaire   +2 more sources

Engineering Osteoimmune Responses with Functionalized Orthopedic Implants for Post‐Operative Osteosarcoma Treatment

Advanced Science, EarlyView.
Osteosarcoma is the most common primary bone tumor with limited treatment options and a terrible prognosis. This review provides a comprehensive summary of the recent development of osteoimmunomodulatory implants for post‐operative osteosarcoma treatment, of which the potential utility in evoking durable anti‐osteosarcoma immunity and accelerating bone
Yilong Dong, Lingshuang Wang, Hui Zhang, Menghuan Li, Zhong Luo, Yan Hu, Chunyuan Cai   +6 more
wiley   +1 more source

Deficiency of interleukin-1 receptor antagonist: A systematic review. [PDF]

Arch Rheumatol
Gonçalves Barros WR, Gonçalves Júnior J.   +1 more
europepmc   +1 more source

The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice. [PDF]

Int J Mol Sci, 2022
Ku EJ, Kim BR, Lee JI, Lee YK, Oh TJ, Jang HC, Choi SH.   +6 more
europepmc   +1 more source

Interleukin-1 Receptor Antagonist Protein [PDF]

, 2020
openaire   +1 more source

Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.

, 1994
Frederick W.K. Tam, Jennifer Smith, S. J. Cashman, Y Wang, EM Thompson, Andrew J. Rees   +5 more
openalex   +1 more source